Fidelity Investments’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-10,207
| Closed | -$18.9K | – | 5678 |
|
|
2023
Q1 | $18.9K | Sell |
10,207
-67,591
| -87% | -$83.7K | ﹤0.01% | 3864 |
|
|
2022
Q4 | $86.4K | Sell |
77,798
-766,989
| -91% | -$1.09M | ﹤0.01% | 3265 |
|
|
2022
Q3 | $1.98M | Sell |
844,787
-421,024
| -33% | -$1.49M | ﹤0.01% | 2428 |
|
|
2022
Q2 | $3.83M | Buy |
1,265,811
+1,158,847
| +1,083% | +$5.64M | ﹤0.01% | 2316 |
|
|
2022
Q1 | $726K | Sell |
106,964
-238,667
| -69% | -$1.7M | ﹤0.01% | 2867 |
|
|
2021
Q4 | $2.89M | Sell |
345,631
-445,303
| -56% | -$3.67M | ﹤0.01% | 2482 |
|
|
2021
Q3 | $5.88M | Hold |
790,934
| – | – | ﹤0.01% | 2313 |
|
|
2021
Q2 | $5.38M | Buy |
790,934
+49,900
| +7% | +$415K | ﹤0.01% | 2310 |
|
|
2021
Q1 | $7.61M | Buy |
741,034
+623,260
| +529% | +$6.83M | ﹤0.01% | 2138 |
|
|
2020
Q4 | $824K | Sell |
117,774
-45,100
| -28% | -$351K | ﹤0.01% | 2564 |
|
|
2020
Q3 | $1.33M | Sell |
162,874
-401,100
| -71% | -$2.49M | ﹤0.01% | 2376 |
|
|
2020
Q2 | $3.89M | Hold |
563,974
| – | – | ﹤0.01% | 2118 |
|
|
2020
Q1 | $2.68M | Sell |
563,974
-674,800
| -54% | -$3.88M | ﹤0.01% | 2120 |
|
|
2019
Q4 | $10.8M | Buy |
1,238,774
+500,600
| +68% | +$2.71M | ﹤0.01% | 1818 |
|
|
2019
Q3 | $2.46M | Sell |
738,174
-181,403
| -20% | -$726K | ﹤0.01% | 2223 |
|
|
2019
Q2 | $4.55M | Sell |
919,577
-87,297
| -9% | -$464K | ﹤0.01% | 2119 |
|
|
2019
Q1 | $6.24M | Sell |
1,006,874
-241
| -0% | -$1.16K | ﹤0.01% | 2010 |
|
|
2018
Q4 | $3.39M | Sell |
1,007,115
-1,197,332
| -54% | -$5.59M | ﹤0.01% | 2152 |
|
|
2018
Q3 | $14.3M | Sell |
2,204,447
-737,885
| -25% | -$5.49M | ﹤0.01% | 1822 |
|
|
2018
Q2 | $22.5M | Sell |
2,942,332
-30,000
| -1% | -$433K | ﹤0.01% | 1669 |
|
|
2018
Q1 | $66.4M | Buy |
2,972,332
+343,942
| +13% | +$7.63M | 0.01% | 1167 |
|
|
2017
Q4 | $33.5M | Sell |
2,628,390
-644,036
| -20% | -$9.47M | ﹤0.01% | 1483 |
|
|
2017
Q3 | $51M | Sell |
3,272,426
-699,590
| -18% | -$9.89M | 0.01% | 1298 |
|
|
2017
Q2 | $53.6M | Sell |
3,972,016
-74,300
| -2% | -$1.59M | 0.01% | 1266 |
|
|
2017
Q1 | $82.4M | Buy |
+4,046,316
| New | +$85.7M | 0.01% | 1073 |
|
Other funds holding JNCE
Fidelity Investments's JNCE Position: Q2 2023 in Review
Fidelity Investments sold out of Jounce Therapeutics, Inc. Common Stock (JNCE) in Q2 2023, closing a stake of 10,207 shares — an estimated $18.9K sold.
Fidelity Investments first reported a position in JNCE in Q1 2017 and held it in 25 quarters. The position peaked at $82.4M in Q1 2017. 1 fund tracked by Wall St. Rank holds JNCE as of Q2 2023.
- Fidelity Investments reported no remaining Jounce Therapeutics, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
- Fidelity Investments sold 10,207 Jounce Therapeutics, Inc. Common Stock shares in Q2 2023, an estimated $18.9K.
- Fidelity Investments first reported a position in Jounce Therapeutics, Inc. Common Stock in Q1 2017 and held it in 25 quarters.
- Fidelity Investments's Jounce Therapeutics, Inc. Common Stock position peaked at $82.4M in Q1 2017.
- 1 fund tracked by Wall St. Rank held Jounce Therapeutics, Inc. Common Stock as of Q2 2023.
Based on Fidelity Investments's 13F filing for Q2 2023, filed 11 Aug 2023.